Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on February 13, 2024. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

CUSTOMIZED ANTIBODY SERVICE & PLASMID PREPARATION (AMBIS 2210574)

Awarded
NOI-NIAID-24-2210574Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

General Info

Contract Value

$54,900

NAICS

541380 - Testing Laboratories and Services

Place of Performance

Rockville, MD, 20852, USA

Set-Aside

NONE

Award Issued Date

Documents

1

Vendor+rep+52.204-26+OCT+2020.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Posted

Presolicitation

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Niaid
Contacts2 people available
OfficeBETHESDA, MD, 20892, USA

Full Description

Show more
Description: This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Genscript USA Incorporated, 860 Centennial Avenue, Piscataway, NJ 08854-3918, United States, to procure customized antibody production services. This is a follow-on purchase of customized antibodies and plasmid production currently used by the Laboratory of Immunogenetics (LIG), Antibody Biology Unit (ABU). It is important to ensure continuity of results. Only one award will be made as a result of this solicitation. This will be awarded as a firm-fixed price type of contract. The LIG/ABU has a current requirement for the production of human monoclonal antibodies and plasmids for a large number of antibody heavy and light chains. Project Description: The requested Gene to Antibody-Customized Service (rAb) and CloneArk Plasmid Preparation are required to help identify antibodies against malaria, tuberculosis, and COVID-19 for potential vaccine candidates. The current requirements are as follows: # Description Qty 1 HTP Gene to Antibody-Customized Service: rAb, description # SC1946-Ab-C 100 2 Research Grade CloneArk Plasmid Preparation (100'g), description # SC1849 200 The human monoclonal antibodies and plasmids must have specific criteria: Antibodies and plasmids must be ready by 4-6 weeks post-order. Must be priced not more than $500 per monoclonal antibody (mAb) protein production from 40mL of culture. Must be priced not more than $25 per 100'g plasmid. We have previously worked with Genscript to customize these antibodies and plasmid production. Genscript USA Incorporated is the only vendor to replicate the customized antibodies and plasmid preparation. Period of Performance(s) are as follows: One (1) year after date and acceptance of award. Delivery at the following location: NIAID, LIG, ABU, 5625 Fishers Lane, Rockville, MD 20852. The statutory authority for this sole source requirement is 41 U.S.C. 253 (c) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A SOLICITATION FOR COMPETITIVE QUOTATIONS. All responsible sources that could provide the required services may submit a capability statement that will be considered by email (subject line to reference NOI-NIAID-24-2210574 to Rita Davis at contact@example.gov, by 11:00am eastern standard time Friday, February 23, 2024. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

More opportunities from Department Of Health And Human Services → National Institutes Of Health Niaid

Same awarding agency

NAICS: 811210
New
Federal
1-Year OEM Service Contract - (2) Revvity Celigo S Imaging Instruments (VRC)
Solicitation # NOI-NIAID-27-2279300
The National Institutes of Health NIAID intends to award a firm-fixed price sole source contract to Revvity Health Sciences, Inc. for a one-year maintenance and service agreement for two Revvity Celigo S imaging instruments. The period of performance is scheduled from November 15, 2026, through November 14, 2027. This procurement is categorized under NAICS code 811210 for electronic and precision equipment repair and maintenance. The government is utilizing statutory authority 41 U.S.C. 3304(a)(1) and FAR 6.302.1(b)(1)(i), asserting that Revvity Health Sciences is the only responsible source capable of satisfying the requirement due to their proprietary access to diagnostic tools, service documentation, and genuine replacement parts. The scope of work includes priority response for unlimited repair travel, labor, and parts, as well as remote support and minor hardware and software updates to ensure the instruments meet manufacturer specifications. While the government intends to negotiate directly with the OEM, interested qualified sources were invited to submit capability statements by November 4, 2026, to the contracting officer, Linda Smith, and acquisition specialist, Jessica Emerson. The final award is expected to be issued within five days of the notice closing.
Electronic and Precision Equipment Repair and Maintenance

POSTED

3 days ago

DEADLINE

in 6 days
View Details
NAICS: 541715
Federal
2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases
Solicitation # HHS-NIH-NIAID-BAA2026-1
The National Institute of Allergy and Infectious Diseases (NIAID) is soliciting proposals under Broad Agency Announcement HHS-NIH-NIAID-BAA2026-1 to advance the research and development of medical interventions for infectious diseases. This initiative focuses on three primary research areas: the development of needle-free vaccine candidates through early-phase clinical trials; the creation of safe and effective therapeutic candidates for serious infectious diseases, including those resistant to current antimicrobial therapy; and the innovation of in vitro diagnostic technology platforms capable of rapid, automated detection of a broad panel of priority viral pathogens. The program emphasizes alignment with NIH priorities regarding biosafety, biosecurity, and the use of non-animal testing methods. Proposals must be submitted electronically via the NIAID eCPS website by December 8, 2026, at 3:00 PM Eastern Time. Technical proposals are limited to 75 pages and will be evaluated by a peer review group based on technical merit, with the technical plan and personnel qualifications being of paramount consideration. Awards are not based on a common Statement of Work; instead, offerors must propose their own technical plans, milestones, and cost structures using a base and option period format. The resulting contracts will require an accounting system compliant with generally accepted accounting principles and will involve rigorous government inspection and acceptance based on the successful completion of critical milestones.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

20 days ago

DEADLINE

in about 1 month
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS